Lab Members

Masashi Tanaka, M.D.
Postdoctoral Fellow

Studies & Results | Abstracts | Publications | CV

Publications

1. Tanaka M, Fedoseyeva EV, Robbins RC. Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment. J Heart Lung Transplant 2004; in press.

2. Tanaka M, Mokhtari GK, Balsam LB, Zwierzchoniewska M, Cooke DT, Kofidis T, Robbins RC. Cyclosporine A mitigates graft coronary artery disease in murine cardiac allografts: description and validation of novel fully allogeneic model. J Heart Lung Transplant 2004; in press.

3. Tanaka M, Mokhtari GK, Terry RD, Balsam LB, Lee K-H, Kofidis T, Tsao PS, Robbins RC. Overexpression of human copper/zinc-superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Circulation 2004; in press.

4. Tanaka M, Terry RD, Mokhtari GK, Inagaki K, Koyanagi T, Kofidis T, Mochly-Rosen D, Robbins RC. Suppression of graft coronary artery disease by a brief treatment with a selective ePKC activator and a dPKC inhibitor in murine cardiac allografts. Circulation 2004; in press.

5. Tanaka M, Mokhtari GK, Terry RD, Gunawan F, Hoyt EG, Balsam LB, Lee K-H, Tsao PS, Robbins RC. Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. Submitted t J Heart Lung Transplant.

6. Tanaka M, Nakae S, Terry RD, Mokhtari GK, Gunawan F, Balsam LB, Kaneda H, Kofidis T, Tsao PS, Robbins RC. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Submitted to Blood.

7. Tanaka M, Zwierzchoniewska M, Mokhtari GK, Terry RD, Balsam LB, Robbins RC, Fedoseyeva EV. Progression of Alloresponse and Tissue-specific Immunity during Graft Coronary Artery Disease. Submitted to Am J Transplant.